2025 Board Election Results
ACMT is delighted to announce that Joshua King, MD, FACMT will remain on the board for a second term, and we are pleased to introduce our two new Board Members, Gillian Beachamp, MD, FACMT, and Brenna Farmer, MD. New board service terms will officially commence at the 2025 ACMT Annual Scientific Meeting in April. Get to know them more by reading each other their personal statements below.

Gillian Beauchamp, MD, FACMT
My commitment to ACMT: It is an honor to be considered for an opportunity to serve on the ACMT Board. ACMT has been supporting my passion for medical toxicology since 2011 when I joined as an emergency medicine intern at the University of Cincinnati. Throughout residency, fellowship, and my junior faculty years as a medical toxicologist, ACMT has been a consistent source of mentorship, support, and opportunity, and for that, I am both grateful and determined to give back.
I am a practicing emergency physician and medical toxicologist at Lehigh Valley Health Network in eastern Pennsylvania, and am board certified in emergency medicine, medical toxicology, and addiction medicine.
I am a longstanding member of the ACMT Education Committee, where I collaborated to design and implement the online lecture library geared towards fellows; and where I continue to deliver educational content through conversations with ACMT speakers via the Tox in Ten: ACMT Highlights podcast.
I joined the ACMT Journal of Medical Toxicology (JMT) Editorial Board as a fellow-in-training (FIT) member in 2015 and continue to be supported by mentors on the editorial board in my role as a JMT editor for reviews. With the support of our JMT Editor in Chief and senior members of the JMT Editorial Board, I began writing about our field during my FIT year – two of those early FIT publications reflect the ways in which ACMT fosters growth in our community: an editorial on the toxicologist as educator, and one on the toxicologist’s role in community outreach and engagement – early reflections that have continued to resonate on my journey as a committed member of ACMT.
The toxicologist as educator: when a learner can see their potential by engaging with a role model, early career trajectories spring to life. My inspirational experiences with medical toxicology mentors as a medical student at the University of Pittsburgh live on in the work I am committed to today: mentoring, supporting, and coaching preprofessional students, medical students, residents, fellows, and junior faculty. It is because of ACMT mentors that I am core faculty for the medical toxicology fellowship at Lehigh Valley Health Network (LVHN) in eastern Pennsylvania, where I served as the Fellowship Director from 2021-2024.
The toxicologist’s role in community engagement: I am the Vice Chair for Education and Community Engagement at Lehigh Valley Health Network, where I design and implement resources focused on vulnerable populations including community members with substance use conditions and toxicological exposures - particularly those who are victims/survivors of human trafficking. This community outreach work extends to learners and faculty in the acute care setting, nursing and care manager teams, and into the community via partnering agencies. Community engagement emerges from my guiding principles as a medical toxicologist: patient centered care with a focus on harm reduction; education with a focus on mentorship; and community engagement. Medical toxicology inherently bridges education, intellectual and scientific exploration, and engagement with our community – and with ACMT as the source of the building blocks for those bridges, I thank you for considering me for this opportunity to give back to this phenomenal organization.

Brenna Farmer, MD, FACMT
It is with great honor that I seek election to the ACMT Board of Directors. Since joining in 2007 during my fellowship at the New York City Poison Control Center and New York University/Bellevue Hospital Center, I have been deeply committed to advancing ACMT's mission. Over the years, I have taken on several key roles, most notably as chair of the Medication Management Section since 2010. In this capacity, I have worked diligently to elevate the role of toxicologists in critical areas such as formulary, therapeutics, and medication management.
My service extends across multiple committees, including the Education and Clinical Practice and Position Statements Committees. For the Education Committee, I have been instrumental in planning multiple ACMT Annual Scientific Meetings and pre-meetings for NACCT, shaping the educational content to reflect the evolving needs of our field. In the Clinical Practice and Position Statements Committee, I have co-authored position statements on the role of pharmacists in the emergency department, the critical role of medical toxicologists in medication management, and medication safety during the COVID-19 pandemic. I have also had the privilege of presenting at numerous ACMT conferences, most recently at the AACT pre-meeting during the 2024 Annual Scientific Meeting, where I advocated medical toxicologists publishing their experiences using antidotes during times of drug shortage.
I earned my BS in Biology from Western Carolina University, followed by my MD from East Carolina University. My medical training includes a residency in emergency medicine at Vanderbilt University Medical Center, along with a Certificate in Comprehensive Patient Safety Leadership from the American Hospital Association-National Patient Safety Foundation. Additionally, I have expanded my leadership acumen through a dual MBA and MS in healthcare leadership from Cornell University in 2019.
My passion for serving on the ACMT Board of Directors stems from a desire to guide our organization through the ever-evolving landscape of the American healthcare system. Additionally, I am committed to mentoring the next generation of medical toxicologists, helping to shape the future of our field by supporting residents and fellows who are passionate about medical toxicology.

Joshua King, MD, FACMT
It has been an honor and a privilege to serve for the past three years on the ACMT Board of Directors. I am a medical toxicologist who comes to practice from a less common background – nephrology and internal medicine. I serve as a clinician-educator – medical director of the Maryland Poison Center, PD of our clinical toxicology fellowship and APD of nephrology fellowship at the University of Maryland. I teach a lot, I see patients in renal and tox settings; it’s my dream job. In many ways, though, I’m lucky to have it. If I hadn’t taken a chance on an elective with Dr. Ward Donovan in medical school, and then haunted the Blue Ridge Poison Center under Dr. Chris Holstege during my residency, there is a good chance that I would barely know what medical toxicology is. I did not know what it was until I had almost finished medical school. And this bothers me a great deal. Toxicologists are generally the smartest, the most passionate, the most dedicated (and undoubtedly the funniest!) group of physicians out there. But we are few in number, and many physicians of various stripes go through an entire career without ever meeting us in person, talking with us on the phone – or even knowing we exist. Most of my internal medicine and nephrology colleagues (with the notable exception of those who share an institution with a toxicologist) hardly know anything about us. A sizeable number of physicians might never think to involve us in the care of poisoned patients, recognition of toxidromes, managing occupational exposures, addiction medicine practice, you name it. I would very much like this to change.
As I see it, there’s one major problem most of us share, regardless of how we came to toxicology: it’s hard to get someone to pay you to be a toxicologist. Over the past decade, I have come to believe this is the primary problem we face: a struggle for recognition of our value. My dream for medical toxicology is that anyone who finishes fellowship can find appealing, plentiful opportunities to practice toxicology and get paid for it.
My time on the board has enabled me to contribute to the efforts put forth by the ACMT to help further address this problem, as well as many others. ACMT is a tireless advocate for our specialty – this is ultimately thanks to your efforts as members of the College. I have also contributed to the ACMT and the medical toxicology community as an educator; a mentor; a researcher; and an advocate for our value among those outside of toxicology. I would be honored to remain on the Board and continue to further work toward making our specialty easier to do, more scientific, more recognized for another three years, particularly in the area of outreach. Thanks so much for your consideration.